As of 2025-09-15, the EV/EBITDA ratio of Cue Biopharma Inc (CUE) is -0.82. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CUE's latest enterprise value is 32.10 mil USD. CUE's TTM EBITDA according to its financial statements is -39.08 mil USD. Dividing these 2 quantities gives us the above CUE EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.2x - 14.1x | 13.0x |
| Forward P/E multiples | 16.2x - 33.8x | 19.2x |
| Fair Price | (7.93) - (6.84) | (7.86) |
| Upside | -1170.0% - -1021.8% | -1160.4% |
| Date | EV/EBITDA |
| 2025-09-11 | -0.87 |
| 2025-09-10 | -0.86 |
| 2025-09-09 | -0.88 |
| 2025-09-08 | -0.89 |
| 2025-09-05 | -0.90 |
| 2025-09-04 | -0.91 |
| 2025-09-03 | -0.92 |
| 2025-09-02 | -0.92 |
| 2025-08-29 | -0.90 |
| 2025-08-28 | -0.94 |
| 2025-08-27 | -0.99 |
| 2025-08-26 | -1.02 |
| 2025-08-25 | -0.97 |
| 2025-08-22 | -0.99 |
| 2025-08-21 | -0.96 |
| 2025-08-20 | -0.95 |
| 2025-08-19 | -0.97 |
| 2025-08-18 | -0.97 |
| 2025-08-15 | -0.99 |
| 2025-08-14 | -0.92 |
| 2025-08-13 | -0.96 |
| 2025-08-12 | -0.92 |
| 2025-08-11 | -1.00 |
| 2025-08-08 | -1.00 |
| 2025-08-07 | -0.96 |
| 2025-08-06 | -0.90 |
| 2025-08-05 | -1.01 |
| 2025-08-04 | -0.86 |
| 2025-08-01 | -0.81 |
| 2025-07-31 | -0.84 |
| 2025-07-30 | -0.96 |
| 2025-07-29 | -0.98 |
| 2025-07-28 | -0.98 |
| 2025-07-25 | -1.10 |
| 2025-07-24 | -1.14 |
| 2025-07-23 | -1.11 |
| 2025-07-22 | -1.13 |
| 2025-07-21 | -1.10 |
| 2025-07-18 | -1.13 |
| 2025-07-17 | -1.02 |
| 2025-07-16 | -1.05 |
| 2025-07-15 | -0.74 |
| 2025-07-14 | -0.89 |
| 2025-07-11 | -0.87 |
| 2025-07-10 | -0.93 |
| 2025-07-09 | -0.90 |
| 2025-07-08 | -0.80 |
| 2025-07-07 | -0.74 |
| 2025-07-03 | -0.73 |
| 2025-07-02 | -0.72 |